Global Point-of-care Testing Growth Opportunities

出版日: | 発行: Frost & Sullivan | ページ情報: 英文 79 Pages | 納期: 即日から翌営業日

価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.89円
出版日: 2023年11月15日
発行: Frost & Sullivan
ページ情報: 英文 79 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次








  • なぜ成長が難しくなっているのか?
  • The Strategic Imperative 8(TM)
  • ポイントオブケア検査(POCT)業界における上位3つの戦略的重要事項のインパクト
  • 成長機会がGrowth Pipeline Engine(TM)を加速させる


  • 分析範囲
  • セグメンテーション-検査タイプ
  • セグメンテーション-ケアコンティニュアム
  • 主要競合企業
  • 成長指標
  • 成長促進要因
  • 成長抑制要因
  • 予測の前提条件
  • 収益予測
  • 検査タイプ別収益予測
  • 地域別収益予測
  • ケア連続体別収益予測
  • 予測分析
  • 価格動向と予測分析
  • 競合環境
  • さまざまな治療領域におけるPOCT
  • 収益シェア
  • 収益シェア分析
  • 競合マトリックス-治療分野
  • 競合マトリックス-技術マッピング


  • 成長指標
  • 収益予測
  • 地域別収益予測
  • 免疫化学POCT別収益予測
  • 予測分析


  • 成長指標
  • 収益予測
  • 地域別収益予測
  • 分子POCT治療分野別収益予測
  • 予測分析


  • 成長機会1:分子POCT
  • 成長機会2:マルチプレキシング
  • 成長機会3:STI POCT
  • 成長機会4:AMR POCT
  • 成長機会5:ルーチンPOCT
  • 成長機会6:スマートフォンPOCT
  • ケアコンティニュアムにおけるPOCTの将来


  • 次のステップ
  • なぜFrostなのか、なぜ今なのか?
  • 別紙リスト
  • 免責事項
Product Code: K973-55

Molecular POCT Unlocking Growth Potential in the Distributed Diagnostic Data Ecosystem

This study provides an overview of the global point-of-care testing (POCT) industry, which refers to any routine or specialized lab pathology testing conducted rapidly, on-site/near the site of the patient, where care or treatment is provided. COVID-19 radicalization is changing the global diagnostics landscape. Consolidation trends, structural shifts in healthcare settings, and the extension of POCT to sexually transmitted infections (STIs), antimicrobial resistance (AMR), routine testing, oncology, and newborn screening are shaping new frontiers. In the future, therapy areas such as oncology, stroke, and dementia will represent the POCT repertoire.

In developed economies, the proliferation of syndromic testing, multiplexing making inroads in immunoassay, evolution in nucleic acid amplification technology (from PCR to Isothermal Amplification), the use of saliva specimens, and advancements in antimicrobial resistance testing are increasing the market viability. Furthermore, AI/ML-enabled device software functions incorporating predetermined change control plans under the diagnostic data program initiative offer accelerated market opportunities in the United States.

In developing economies, multiparametric platforms have emerged to respond to an escalating POC demand in emergency departments and small-medium labs. In addition, a strong pull toward preventive health is laying the foundation to advance routine testing using emerging blood testing platforms.

A robust multiplex ecosystem tied with the converging potential of diagnostic data creating new revenue streams (e.g., connectivity and digital healthcare technology services) exemplifies the pivot from COVID-19 testing, adapting to changing clinical pathways and greater harmonization of lab-based and non-lab-based diagnostic data for similar tests to build a more sustainable point-of-care ecosystem.

Table of Contents

Strategic Imperatives

  • Why is it Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the Point-of-care Testing (POCT) Industry
  • Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

  • Scope of Analysis
  • Segmentation-Test Type
  • Segmentation-Care Continuum
  • Key Competitors
  • Growth Metrics
  • Growth Drivers
  • Growth Restraints
  • Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast by Test Type
  • Revenue Forecast by Region
  • Revenue Forecast by Care Continuum
  • Forecast Analysis
  • Pricing Trends and Forecast Analysis
  • Competitive Environment
  • POCT Across Different Therapy Areas
  • Revenue Share
  • Revenue Share Analysis
  • Competitor Matrix-Therapy Areas
  • Competitor Matrix-Technology Mapping

Growth Opportunity Analysis- Immunochemistry POCT

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Revenue Forecast by Immunochemistry POCT
  • Forecast Analysis

Growth Opportunity Analysis-Molecular POCT

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Revenue Forecast by Molecular POCT Therapy Areas
  • Forecast Analysis

Growth Opportunity Universe

  • Growth Opportunity 1: Molecular POCT
  • Growth Opportunity 2: Multiplexing
  • Growth Opportunity 3: STI POCT
  • Growth Opportunity 4: AMR POCT
  • Growth Opportunity 5: Routine POCT
  • Growth Opportunity 6: Smartphone POCT
  • Future of POCT in Care Continuum

Next Steps

  • Your Next Steps
  • Why Frost, Why Now?
  • List of Exhibits
  • Legal Disclaimer